Genmab A/SGMABNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P36
Within normal range
vs 5Y Ago
-5.3x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -50.88% |
| Q3 2025 | -81.17% |
| Q2 2025 | 991.92% |
| Q1 2025 | -94.93% |
| Q4 2024 | 203.71% |
| Q3 2024 | 523.65% |
| Q2 2024 | 5.73% |
| Q1 2024 | -70.00% |
| Q4 2023 | -69.58% |
| Q3 2023 | 57.60% |
| Q2 2023 | 535.71% |
| Q1 2023 | -59.14% |
| Q4 2022 | -80.09% |
| Q3 2022 | 36.54% |
| Q2 2022 | 306.67% |
| Q1 2022 | -35.06% |
| Q4 2021 | -19.55% |
| Q3 2021 | 190.85% |
| Q2 2021 | -72.08% |
| Q1 2021 | 88.64% |
| Q4 2020 | 9.62% |
| Q3 2020 | -84.31% |
| Q2 2020 | 1155.76% |
| Q1 2020 | -81.72% |
| Q4 2019 | 174.09% |
| Q3 2019 | 531.76% |
| Q2 2019 | 18.06% |
| Q1 2019 | -91.37% |
| Q4 2018 | 365.39% |
| Q3 2018 | -31.23% |
| Q2 2018 | 31.20% |
| Q1 2018 | -74.73% |
| Q4 2017 | 13933.27% |
| Q3 2017 | -101.85% |
| Q2 2017 | 1808.60% |
| Q1 2017 | -98.09% |
| Q4 2016 | 345.29% |
| Q3 2016 | 12.32% |
| Q2 2016 | 1559.70% |
| Q1 2016 | -102.96% |